Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

REduction of Physical Inactivity Facing the CAncer (RESCA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02867475
Recruitment Status : Completed
First Posted : August 16, 2016
Last Update Posted : August 17, 2016
Sponsor:
Information provided by (Responsible Party):
Centre Antoine Lacassagne

Brief Summary:

Study 1:

The investigator hypothesizes that the level of knowledge about the benefits of physical activity, physical activity level and physical fatigue level observed in cancer patients, would influence their beliefs about physical activity and their intention to engage in AP.


Condition or disease Intervention/treatment Phase
Breast Cancer Other: Physical activity motivation Not Applicable

Detailed Description:

Study 2:

Because of a recent research, it is shown that a narrative message from a peer generates an identification, a sense of self-efficacy and intention to practice in sedentary patients with breast cancer.

The investigator hypothesize that a promotional message about physical activity, issued by a self-determined peer (intrinsic motivation), compared to a non-self-determined peer (extrinsic motivation), generate higher scores of positive beliefs about physical activity and intention to engage in a physical activity program for sedentary patients.

These promotional messages will be delivered through two videos, one featuring the self-determined pair, the other featuring the non-self-determined pair.


Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 422 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Supportive Care
Official Title: Physical Activity in Patients With Cancer: Epidemiological Study of Patients' Beliefs and Promotional Messages Efficiency
Study Start Date : October 2013
Actual Primary Completion Date : December 2015
Actual Study Completion Date : March 2016

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
A
Physical activity motivation
Other: Physical activity motivation
Physical activity motivation




Primary Outcome Measures :
  1. CaBES [ Time Frame: 1 day ]
    psychometric measures: Cancer Beliefs and Exercise Scale Questionnaire


Secondary Outcome Measures :
  1. Multidimensional Fatigue Inventory [ Time Frame: 1 day ]
    Fatigue level determination

  2. Dijon's Score [ Time Frame: 1 day ]
    Physical activity level determination



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 80 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • PS 0-3
  • Patients with breast cancer undergoing chemotherapy treatment
  • neoadjuvant, adjuvant, metastatic, any histological type, any stage breast cancer
  • Sedentary Patients (physical activity score of Dijon less than or equal to 20)

Exclusion Criteria:

  • Patients with PS greater than 3
  • Patients with cognitive disorders not allowing them to understand the questionnaires and study procedures

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02867475


Locations
Layout table for location information
France
Centre Antoine LACASSAGNE
Nice, France, 06189
Sponsors and Collaborators
Centre Antoine Lacassagne
Investigators
Layout table for investigator information
Principal Investigator: Véronique MARI, md Centre Antoine Lacassagne

Layout table for additonal information
Responsible Party: Centre Antoine Lacassagne
ClinicalTrials.gov Identifier: NCT02867475     History of Changes
Other Study ID Numbers: 2013/03 RESCA
First Posted: August 16, 2016    Key Record Dates
Last Update Posted: August 17, 2016
Last Verified: August 2016
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided